REQUEST A DEMO
Total
USD $0.00
Search more companies

Imre es Tarsa Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: IMRE es Tarsa Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Imre es Tarsa Bt. is based in Hungary. The head office is in Kecel. It operates in the Pharmacies and Drug Stores industry. It was established on February 17, 1998. It currently has a total number of 6 (2024) employees. In 2023, the company reported a net sales revenue increase of 12.88%. Its’ total assets recorded a growth of 21.11%. Imre es Tarsa Bt.’s net profit margin increased by 0.12% in 2023.

Headquarters
Vasut u. 3. fszt 2.
Kecel; Bacs-Kiskun; Postal Code: 6237

Contact Details: Purchase the Imre es Tarsa Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Imre es Tarsa Bt. report to view the information.
Outstanding Shares:
Purchase the Imre es Tarsa Bt. report to view the information.
Registered Capital:
Purchase the Imre es Tarsa Bt. report to view the information.
Incorporation Date:
February 17, 1998
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Imre es Tarsa Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.88%
Total operating revenue
13.6%
Operating profit (EBIT)
15.6%
EBITDA
14.67%
Net Profit (Loss) for the Period
15.69%
Total assets
21.11%
Total equity
45.23%
Operating Profit Margin (ROS)
0.13%
Net Profit Margin
0.12%
Return on Equity (ROE)
-12.11%
Quick Ratio
0.06%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?